SV Health Investors

SV Health Investors is a global healthcare investment firm with a 30-year track record of transforming healthcare through strategic investments. Founded in 1993, the firm manages approximately $3.7 billion to $4.0 billion in historical commitments across diversified private equity and venture capital funds. Their investment focus spans biotechnology (including dementia), healthcare growth equity, and medical technology, supporting companies at all stages from early seed to growth and late-stage development.

With offices in Boston and London, SV Health Investors leverages a team of over 50 experienced investment professionals and operating partners who bring deep sector expertise and healthcare industry experience. The firm emphasizes backing diverse entrepreneurs and management teams to build innovative healthcare companies that improve patient outcomes while generating shareholder value. To date, SV has invested in nearly 300 companies, with over 75 achieving successful IPOs or mergers and acquisitions.

SV Health Investors’ portfolio includes companies across healthcare services, digital health, medical devices, and biotechnology sectors. Their hands-on approach combines capital with strategic guidance, helping portfolio companies advance novel treatments and technologies that address unmet medical needs globally. The firm is committed to fostering innovation that benefits patients and drives long-term growth in the healthcare industry.